Table A5. .
Population and Phenotype |
RR (unexpa) |
95% CI of RR– |
RR (expb) |
95% CI of RR– |
RR (interactionc) |
95% CI of RR |
χ2 | P | Adjusted Pd |
DBS: | |||||||||
Alle | .84 | .48–1.46 | 2.34 | 1.12–4.91 | 2.79 | 1.11–7.01 | 4.9 | .03f | .03 |
CPO | .87 | .35–2.19 | 4.22 | 1.39–12.85 | 4.83 | 1.14–20.43 | 4.5 | .03 | .03 |
CL/P | .83 | .44–1.55 | 1.97 | .89–4.38 | 2.38 | .86–6.55 | 2.8 | .09 | .12 |
Iowa triad: | |||||||||
Alle | .65 | .37–1.15 | 4.54 | 1.20–17.15 | 7.03 | 1.67–28.98 | 8.7 | .003f | .02 |
No anomaliesg | .60 | .33–1.10 | 4.61 | 1.20–17.76 | 7.72 | 1.80–32.83 | 9.2 | .002 | .03 |
CLO | .48 | .15–1.50 | 6.21 | 1.20–31.64 | 12.9 | 1.90–88.01 | 7.3 | .007 | .01 |
CPO | .63 | .26–1.55 | 6.95 | 1.48–31.76 | 11.1 | 1.95–60.70 | 8.3 | .004 | .04 |
CL/P | .75 | .39–1.41 | 3.33 | .78–14.12 | 4.45 | .94–21.43 | 3.8 | .05 | .13 |
DBS and Iowa triad: | |||||||||
Alle | .70 | .47–.97 | 2.23 | 1.20–3.71 | 3.17 | 1.59–6.13 | 9.5 | .002 | <.001 |
No anomaliesg | .69 | .45–.96 | 2.21 | 1.19–3.72 | 3.21 | 1.62–6.34 | 9.5 | .002 | <.001 |
CPO | .60 | .37–1.19 | 4.25 | 1.51–7.33 | 7.13 | 1.88–13.41 | 11.4 | <.001 | <.001 |
CL/P | .79 | .49–1.13 | 1.76 | .91–3.17 | 2.23 | 1.08–4.81 | 3.7 | .05 | .03 |
RR of GSTT1-null genotype in nonsmoking mothers.
RR of GSTT1-null genotype in smoking mothers.
RR of the interaction effect between GSTT1-null genotype and maternal cigarette smoking.
Adjusted for vitamin and alcohol use.
Includes data from all subjects with nonsyndromic OC.
The combined P value by use of Fisher’s method is .0009, which remains significant after correction for multiple tests (see the “Material and Methods” section).
Includes data from subjects without other minor anomalies.